Patents Assigned to Allergy Limited
  • Cyanocobalamin (vitamin B12) treatment in allergic disease
    Patent number: 6255294
    Abstract: Vitamin B12 is administered to allergy patients via mucosal membranes in a series of lozenges and other patient friendly transmucosal modes of delivery given repeatedly over a period of time to reduce the symptoms and IgE antibodies associated with allergic diseases such as allergic rhinitis (hay fever), and allergic asthma.
    Type: Grant
    Filed: December 28, 1999
    Date of Patent: July 3, 2001
    Assignee: Allergy Limited
    Inventors: Hepburn T. Armstrong, John A. Wise, Ernest T. Armstrong